Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Zynerba Pharmaceuticals Inc
ZYNE
Healthcare
Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused...
on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ZYNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(3)
•••
Nibinator
X
Comment by
Nibinator
on Aug 20, 2023 5:23pm
RE:Kevin Harrington Discusses FSD Pharma
Eben ca alors cest la bomba
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 13, 2023 4:08am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
Advance United Holdings Announces Name Change
posted Sep 20, 2023 9:00am by
Advance United Holdings Inc
-
|
Advance United is pleased to announce that, effective Sept 25, 2023, it will be changing its corporate name to "Advanced Gold Exploration Inc." Mr. Jim Atkinson CEO comments: "We are making this change to reflect our focus on the prospective gold projects Melba, Doyle and the Paint Lake JV in our portfolio. We are actively seeking partners for ...read more
(0)
•••
MandyMoore
X
Post by
MandyMoore
on Apr 13, 2023 2:43am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
MarcLee
X
Post by
MarcLee
on Jul 15, 2022 9:43pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
MarcLee
X
Post by
MarcLee
on Jun 03, 2022 5:26am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
(0)
•••
MarcLee
X
Post by
MarcLee
on Jun 02, 2022 12:37am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
MarcLee
X
Post by
MarcLee
on May 11, 2022 1:51am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 30, 2022 11:49pm
FSD Pharma Inc: Lucid MS Video
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 23, 2022 2:45am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 16, 2022 11:21am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 09, 2022 12:51pm
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 07, 2022 12:44pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(0)
•••
MarcLee
X
Post by
MarcLee
on Apr 06, 2022 2:05am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
(0)
•••
MarcLee
X
Post by
MarcLee
on Feb 19, 2022 2:02am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(0)
•••
MarcLee
X
Post by
MarcLee
on Feb 04, 2022 11:12am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Industry Expert Details How to Invest in Copper
Company Announces Name Change as They Turn Full Focus to Gold
SolarBank Completes Sale of 21MW Community Solar Sites to Honeywell International for $41mn
A Digital Advertising Company Announces Updated Commercial Agreements with Large National Retailers
Bob Moriarty: Lithium South (TSXV:LIS) is a Real Deal Lithium Company